 |
Recombinant humanized anti-LOXL2 monoclonal antibody |
|---|---|
| Trade Name | |
| Orphan Indication | Idiopathic pulmonary fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2011-04-18 00:00:00 |
| Sponsor | Gilead Sciences, Inc.;199 East Blaine St.;Seattle, Washington, 98102 |
